Corporate Tech Investors

ElevateBio

ElevateBio is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

ElevateBio is a cell and gene therapy technology company built to power the development of transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built world-class facilities, and integrated diverse technology platforms necessary for rapid innovation and commercialization of cell, gene, and regenerative therapies. The company has built an initial technology stack, including gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/24/2021

Transaction History

Our records indicate that ElevateBio invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

David Hallal

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

ElevateBio has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Element AI | Eli Lilly and Company

Share this article

About Our Corporate Tech Investor Database

Our corporate equity investment data comes from VentureDeal.com, a leading supplier of corporate VC funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary